Syntegon Increases Order Income and Sales Compared to 2020
Syntegon announced its well-established machine and service portfolio enabled the company to meet the high demand for both new equipment and modernizations fueled by the ongoing Covid-19 pandemic, and significantly increased order income and sales in 2021 compared to 2020 by:
- Supporting vaccine production with pharmaceutical filling and inspection technology
- Answering rising demands for automation and providing solutions for sustainable packaging standards in the food industry
- Expanding service activities supporting customers with digital solutions
- Increasing corporate focus on environmental, social, and corporate governance
Benefitting further from global economic recovery effects in the special machinery industry, Syntegon increased its order income and sales significantly. Order income rose by 13.1 percent from 1.33 billion EUR in 2020 to 1.50 billion EUR in 2021, while the total sales increased by 9.9 percent from 1.28 billion EUR in 2021 to 1.41 billion EUR in 2022.
Global machine sales accounted for two-thirds of the total sales; the remaining third was earned with Syntegon’s service offering. The 2021 sales were generated in roughly equal parts in key markets around the globe, with 35 percent in Europe, 30 percent in North America, and another 35 percent in Asia and the rest of the world.
Shaping innovations and trends in 2021
While sustainable packaging solutions continued to drive innovations in the food industry in 2021, the Covid-19 pandemic boosted the trend towards automation. The Syntegon food business experienced a particularly high demand in North America, as many food manufacturers started replacing manual work by fully automated packaging solutions.
The service business has also seen increased demand, particularly in China. Limited travel possibilities further increased the need for digital remote service solutions. The pandemic’s effect was most noticeable in the pharma business, which generated 57 percent of Syntegon’s total sales in 2021. In addition to investing in vaccine production, pharmaceutical manufacturers rely on processing, filling, and inspection technology from Syntegon for their liquid and solid pharmaceuticals.
Commitment to a better life
In 2021, Syntegon strengthened its efforts towards environmental, social, and corporate governance (ESG). The company committed to the UN Global Compact and successfully completed its first sustainability assessment by the global rating agency EcoVadis.
One of the company’s goals is to reduce its CO2 emissions 25 percent by 2025 compared to 2019. In addition, Syntegon aims to make all its food packaging machines ready to process sustainable materials by the end of this year.
Another important aspect is the company’s responsibility towards its employees. A global employee survey recently revealed results well above the industry average with high engagement and commitment rates.
System competence for the food and nutraceutical industries
Several innovations launched in 2021 highlighted the company’s dedication to sustainability. For instance, Syntegon and Huhtamaki developed a fully recyclable paper-based alternative to plastic blisters for tablets and capsules that won the German packaging award for sustainable packaging.
Syntegon also catered to the growing demand for automation and flexibility by bringing two innovative robotic solutions to the market: the integrated Sigpack TTMD top load cartoner and the scalable, modular Robotic Pick-and-Place platform RPP. Both ideally complement Syntegon’s system competence for the food industry, which ranges from process technology to primary, secondary, and tertiary packaging. Moreover, Syntegon expanded its inline filling portfolio for preformed containers with the new LFS filling machine for clean and ultra-clean hygiene levels of liquid and viscous products.
Global partnerships and innovations for the pharmaceutical industry
Syntegon’s pharma business won a prestigious award in 2021: the PDA Drug Delivery Innovation Award in the “Partnership Innovation” category for Versynta microBatch. Syntegon is developing the fully automated, gloveless production cell together with Vetter to address the need for smallest batches of highly effective liquid drugs.
Together with Amgen, Syntegon has set new standards by implementing the first fully validated visual inspection system using Artificial Intelligence (AI). Collaborations are also driving continuous manufacturing of oral solid dosage (OSD) forms.
Syntegon has entered a strategic partnership with Bayer and signed an agreement with Shanghai Pharmaceuticals to further advance this technology and establish it as a standard in the pharmaceutical industry.
Boosting services and digital solutions
The continuous expansion of the company’s service and digital solutions portfolio played an essential part in catering even better to daily customer needs for Syntegon’s 66,000 installed machines around the globe. The availability of remote services was further increased to offer both food and pharmaceutical manufacturers support through additional digital channels.
New service agreements minimize costumers’ production risks by providing regular inspections, maintenance, and customized training. In addition, they facilitate comprehensive planning of annual budgets and capacities. The Syntegon service network has also started to optimize its global spare parts supply chain to achieve an even higher level of availability, delivery, reliability, and transparency.
Exciting developments ahead
In 2022, Syntegon will further extend its digital solutions portfolio. It will include a new digital customer platform with an improved Human Machine Interface (HMI) to help customers from the food and pharmaceutical industries monitor and optimize their production performance and ensure high levels of quality and efficiency. Syntegon will showcase further innovations at numerous trade shows worldwide. Visitors to Pack Expo in Chicago, for instance, will be introduced to new technologies for even gentler handling of sensitive products such as cookies and bars. At Achema in Frankfurt, Germany, Syntegon will present its new developments for small and micro batch handling of liquid pharmaceuticals, as well as for continuous manufacturing of oral solid dosage forms. For more information, visit www.syntegon.com.